Skip to main content
HURA logo

HURA · TuHURA Biosciences, Inc./NV

Track HURA — free
$2.06 -0.03 (-1.33%)
Market Cap
$133.19M
Shares
63.73M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.09 Open$2.05 Day$2.04–2.10 52W close$0.44–3.15 Avg vol 30d241K Short int6.3M · 9.8% float · 27.9d Short vol56% DataJan 2020–Sep 2026 Filing10-Q · Aug 14

Up next

filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$30.62M
Trailing 12 months
Revenue growth YoY
Year over year
Operating margin
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
-22.5%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+43.6%
Year over year · more shares
Price change (1Y)
-14.0%
Trailing year
Short interest
9.8%
Latest settlement · 27.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +15%
above
Price vs 50-day avg −4%
below
RSI (14) 48
neutral
MACD trend Positive
52-week position 61%
mid-range
Momentum
relative strength
Neutral
1-month return −8%
trailing
6-month return +7%
trailing
YTD return +176%
this year
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow Distributing
-1% holders QoQ · +23 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.84% of float · ▼ -0.9% MoM · 27.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
89 holders — near 3-yr high, broad support
Squeeze score 78
high risk · 0–100
Fundamentals
Strong
EPS growth +48%
Y/Y
Free cash flow $-27.7M
Balance sheet $3.7M
net cash
Quant / Vol
risk profile
Very High
Volatility 129%
annualized · 1-yr
Max drawdown −83%
past year
ATR 5.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+15% Bullish
Price vs 50-day avg
−4% Neutral
RSI (14)
48 Neutral
MACD trend
Positive Bullish
52-week position
61% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow Distributing
-1% holders QoQ · +23 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.84% of float · ▼ -0.9% MoM · 27.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
89 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $0 Now $2 · 61% Range high $3
vs 200-day avg +15% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HURA
TuHURA Biosciences, Inc./NV
this stock
$133.19M +176.1% 9.8%
VRTX
Vertex Pharmaceuticals Inc / Ma
$130.06B +13.9% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
$79.83B +2.3% +20.8% 19.2 2.5%
ARGX
Argenx SE
$60.93B +18.4% 2.0%
CSLLY
Csl Ltd
$59.64B 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
89
% held
14.1%
Net QoQ
-532.0K sh
Top holder
VANGUARD CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
37
View
Short & Settlement
Short Interest Falling
Shares short
6.3M
Days to cover
27.9d
Change
-55.5K sh
View
Short Volume
Short vol %
56%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$3.4K
As of
Aug 31, 2026
View
Off-Exchange
Off-exchange %
49.1%
Week of
Aug 10, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Laurel Lee
Amount
$50.0K–$100.0K
Traded
Jul 13, 2025
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-30.1M
EPS diluted
$-0.63
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 17, 2026
This year
24
View
Exempt Offerings
Offering
$3.0M
Filed
Nov 10, 2025
View
Earnings & Events
Earnings Calls
Last call
Sep 14, 2026
View

Performance

5D 20D 120D MTD YTD
HURA +3.0% -8.3% +7.2% -1.9% +176.1%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY +2.3% -7.5% -11.0% -1.3% +164.3%
Key facts CIK 1498382 CUSIP 898920103 13F (30d) 2 filings 2 filers Visit website Investor relations